Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinoma
Beta-1,4-galactosyltransferase II is found to be associated with the alterations of tumor-related glycosylation. However, the clinical significance of beta-1,4-galactosyltransferase II in non-metastatic clear-cell renal cell carcinoma has not been reported up to now. Herein, our researches suggested...
Saved in:
| Main Authors: | Haijian Zhang, Yidong Liu, Huyang Xie, Qiang Fu, Zheng Liu, Yu Zhu, Le Xu, Weijuan Zhang, Yuanfeng Yang, Jiejie Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-02-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317691417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Upregulation of TRPS1 promotes proliferation, migration, and invasion in ovarian clear cell carcinoma and correlates with poor patient prognosis
by: Jingfang Liu, et al.
Published: (2025-04-01) -
The impact of radiotherapy on the prognosis of metastatic clear cell renal cell carcinoma after surgery
by: Xuwen Li, et al.
Published: (2025-05-01) -
HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
by: Xu Chen, et al.
Published: (2020-05-01) -
Overexpression of MMP14 is associated with poor prognosis and immune cell infiltration in colon cancer
by: Na Li, et al.
Published: (2025-04-01) -
MtDNA copy number enrichment is associated with poor prognosis and eosinophilic morphology in clear cell renal cell carcinoma
by: Sarah Bellal, et al.
Published: (2025-07-01)